Power Up! CRISPRi & CRISPRa Tools for Genome-Wide Screening

Horizon Discovery is leveraging these technologies to address novel research questions and deliver insights into essential gene function, hypomorphic expression, and gene dominance.

Event Details:Power Up! CRISPRi & CRISPRa Tools for Genome-Wide ScreeningDate(s):

Power Up! CRISPRi & CRISPRa Tools for Genome-Wide Screening from thescientistllc on Vimeo.

Forward genetic screening with CRISPR-Cas9 has created remarkable new opportunities for biological discovery. The power of complete gene knockout in a pooled screening platform has delivered novel target ID, tackled complex mechanism of action, and driven the design of efficient and economical patient stratification for clinical studies. Using transcriptional regulation with catalytically-dead Cas9 (dCas9), both loss-of-function studies (CRISPR interference, CRISPRi) and gain-of-function studies (CRISPR activation, or CRISPRa) are now possible at a genome-wide level. Horizon Discovery is leveraging these technologies to address novel research questions and deliver insights into essential gene function, hypomorphic expression, and gene dominance. In this webinar we will introduce these new powerful tools and share our screening datasets. Attendees can interact with our expert speaker during the live webinar, asking questions and discussing their experiences.

Topics to be covered:

View the Video Now

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform